Newly Approved Drug Therapies (341): Flovent Rotadisk, GlaxoWellcome

Description of Medical Areas

About the FDA Approved Listings

Drugs Approved by the FDA

Drug Name: Flovent Rotadisk

The following information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: GlaxoWellcome
Approval Status: Approved November 1997
Treatment for: asthma

General Information

Flovent Rotadisk, a fluticasone inhalation powder, has been approved for the maintenance treatment of asthma in patients four and older. The corticosteroid is dosed twice daily and is available in strengths of 50 mcg and 100 mcg for children and adults and in a 250 mcg for adults.

Back to Drug Listing

Drug listing last updated on June 20, 2008

Patient Resources: [ Trial Listing ] [ Notification Services ] [ Drug Directories ]
[ About Clinical Research ] [ Patient Resources ] [ Patient Bookstore ]
Professional Resources: [ Research Center Profiles ] [ Industry Provider Profiles ] [ Jobs in Clinical Research ]
[ Industry News ] [ Professional Resources ] [ Professional Bookstore ]
General: [ Search ] [ Site Map ] [ Your Privacy ] [ CW World ] [ Home ]